Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Metabolix Opens First European Office

Bioscience company Metabolix, Inc. (MBLX: Quote) said Wednesday that it has opened its new office in Cologne, Germany.

The new office marks the first expansion for Metabolix outside of the United States and will coordinate business development, customer service and technical support to business partners and biopolymer customers based in Europe.

Located in the BioCampus Cologne life science park, the space will enable the company to directly access the European market for biopolymers and will serve as a coordination point for its regional initiatives in renewable chemicals.

According to the Freedonia Group, global demand for bioplastics is expected to more than triple through 2015, with Western Europe remaining the largest consumer of bioplastic materials. With more than 700 issued and pending patents, Metabolix has led the industry in the development of a family of biopolymers called PHAs, or polyhydroxyalkanoates.

Click here to receive FREE breaking news email alerts for Metabolix Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.